{ "presentation": "complete-card", "format_version": 3, "overview": "Lp(a) is a cholesterol-carrying blood particle whose level is largely inherited. A separate blood test can reveal heart and blood-vessel risk that a routine cholesterol panel misses, even when LDL cholesterol looks normal.", "overview_sources": "MedlinePlus · 2025", "overview_source_ids": [ "self22b8-lp-a-medlineplus" ], "sections": [ { "role": "explanation", "title": "What the test measures", "items": [ { "label": "An LDL-like particle with an extra protein.", "text": "Its attached protein is called apo(a). High Lp(a) contributes to artery disease and calcification of the aortic heart valve.", "source": "American College of Cardiology · 2023", "source_ids": [ "self22b8-lp-a-acc-units" ] }, { "label": "Usually one adult measurement, rather than regular tracking.", "text": "The 2026 U.S. multisociety guideline recommends measuring Lp(a) at least once in adulthood. It usually stays relatively stable, and food or exercise changes have little effect on the number.", "source": "American College of Cardiology · 2026", "source_ids": [ "self22b8-lp-a-acc-guideline" ] }, { "label": "A blood draw with test-specific preparation.", "text": "Labcorp's standalone test uses an in-person blood sample, lists no special preparation and estimates results 2–4 days after lab arrival. Other appointments have their own instructions.", "source": "Labcorp OnDemand", "source_ids": [ "self22b8-lp-a-labcorp" ] }, { "label": "mg/dL and nmol/L measure different things.", "text": "mg/dL measures particle mass; nmol/L measures particle number. Particle sizes vary, so there is no accurate universal conversion factor. A comparison needs the original number, unit and date.", "source": "American College of Cardiology · 2023", "source_ids": [ "self22b8-lp-a-acc-units" ] }, { "label": "Common high-risk cutoffs are 50 mg/dL or 125 nmol/L.", "text": "The NLA's intermediate bands start at 30 mg/dL or 75 nmol/L; below those is its lower-risk range. These are separate thresholds in each unit. Risk increases gradually; a lab flag is not a complete personal risk assessment.", "source": "National Lipid Association · 2024", "source_ids": [ "self22b8-lp-a-nla-thresholds" ] } ] }, { "role": "benefits", "title": "What knowing it can change", "items": [ { "label": "A clearer plan for risks that can change.", "text": "A high result can strengthen the case for managing LDL cholesterol, blood pressure and smoking with a clinician. Diet and exercise can still improve overall heart health even when Lp(a) barely moves. Testing supplies information; it does not itself prevent an event.", "source": "MedlinePlus · 2025", "source_ids": [ "self22b8-lp-a-medlineplus" ] }, { "label": "An inherited finding can matter to close relatives.", "text": "The NLA supports screening first-degree relatives—parents, siblings and children—after elevated Lp(a) is identified. Each relative needs their own result and risk assessment; one person's number does not diagnose the whole family.", "source": "National Lipid Association · 2024", "source_ids": [ "self22b8-lp-a-nla-thresholds" ] } ] }, { "role": "cautions", "title": "Good to know before reacting", "items": [ { "label": "High risk is not a prediction that an event will happen.", "text": "Interpretation includes family history, other lipids and blood pressure. Low Lp(a) does not cancel other risks. LDL cholesterol, ApoB and, in selected cases, imaging add different information rather than replacing this test.", "source": "American College of Cardiology · 2026", "source_ids": [ "self22b8-lp-a-acc-guideline" ] }, { "label": "Stable does not mean unchangeable in every situation.", "text": "The NLA notes that specific conditions can justify another measurement, particularly for intermediate results. A repeat has a clinical reason; the once-in-adulthood recommendation is not an absolute ban on retesting.", "source": "National Lipid Association · 2026", "source_ids": [ "self22b8-lp-a-nla-simplified" ] }, { "label": "A lower number is not enough to establish a treatment benefit.", "text": "Niacin lowers Lp(a) but is not recommended: cardiovascular benefit is unproven and adverse effects limit use. Statins may slightly raise Lp(a) while treating LDL; a result alone is not a reason to stop a prescription.", "source": "American College of Cardiology · 2023", "source_ids": [ "self22b8-lp-a-acc-units" ] }, { "label": "Targeted-drug headlines still need outcome evidence.", "text": "On September 4, 2026, Novartis reported that pelacarsen lowered Lp(a) but missed its cardiovascular-event endpoint in people with established cardiovascular disease. This is a sponsor's topline announcement, with full results still to come; it does not settle every other drug's prospects.", "source": "Novartis · 2026", "source_ids": [ "self22b8-lp-a-novartis-horizon" ] } ] }, { "role": "community", "title": "Living with the result: community experiences", "items": [ { "label": "Insurance stories differ even within one discussion.", "text": "A reader asking after a brother's high result was told insurance would not cover testing. Replies described both covered draws and out-of-pocket bills, plus comparisons of single tests and larger panels. Coverage and prices remain individual questions.", "source": "Community · Reddit · r/Cholesterol", "source_ids": [ "self22b8-lp-a-reddit-access" ] }, { "label": "Knowing can bring relief, anxiety or a sense of direction.", "text": "One poster hesitated to test because they feared learning about a risk they could not change. A respondent felt relieved by a normal result; another valued knowing a high result while pursuing lipid care. Replies disagreed about whether to test immediately or wait.", "source": "Community · Reddit · r/PeterAttia · 2025", "source_ids": [ "self22b8-lp-a-reddit-anxiety" ] }, { "label": "Getting the test can require a separate conversation.", "text": "A r/Cholesterol discussion includes frustration about delayed testing, refusals followed by self-paid testing, and a contrasting report of a doctor adding it after the new guideline. One person kept results with the same lab and unit for easier comparison.", "source": "Community · Reddit · r/Cholesterol", "source_ids": [ "self22b8-lp-a-reddit-routine" ] }, { "label": "Changes after medication can be confusing.", "text": "A poster reported Lp(a) rising from 78 to 155 nmol/L after starting a statin while LDL fell from 105 to 59. Replies questioned whether the medicine explained the entire change; another described steadier readings. The thread cannot establish cause or a treatment choice.", "source": "Community · Reddit · r/PeterAttia · 2026", "source_ids": [ "self22b8-lp-a-reddit-statin" ] }, { "label": "Percentile searches can become a late-night worry loop.", "text": "Accounts describe shock after a high result, family messages and repeated screenshot comparisons. Some find it easier to record the value with ApoB and bring written questions to one ongoing clinician conversation instead of checking the same number like a daily score.", "source": "Community", "provenance": "preserved-community-record" }, { "label": "A single add-on test and a large panel feel different.", "text": "People describe primary-care or cardiology draws, cash tests and Function- or Superpower-style panels. Results may take days to a week in these accounts; some need extra follow-up visits. Large reports can scatter attention across many flags, and repeated panels add cost without necessarily answering the Lp(a) question.", "source": "Community", "provenance": "preserved-community-record" }, { "label": "Family conversations need room for individual decisions.", "text": "Siblings and adult children sometimes become interested in testing after one high result. Accounts also include young athletes with family history and relatives frightened by group messages. A shared result does not determine a relative's risk or training needs.", "source": "Community", "provenance": "preserved-community-record" }, { "label": "Supplement promises and trial hope pull in opposite directions.", "text": "Discussion includes skepticism about high-dose niacin, powders advertised as Lp(a) crushers and prescription changes prompted by memes. Others follow Attia interviews, lipidologists and drug-trial news with hope. The practical questions remain who explains the result and what changes in their own care.", "source": "Community", "provenance": "preserved-community-record" } ], "groups": [ { "title": "Access, coverage and the test request", "item_indices": [ 0, 2, 5 ] }, { "title": "Results, medication changes and online searching", "item_indices": [ 1, 3, 4 ] }, { "title": "Family conversations and treatment hopes", "item_indices": [ 6, 7 ] } ] } ], "related": [ "apob", "home-blood-pressure", "function-superpower" ] }